A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with the use of PSA or MRI screening.
What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...
In a cohort of US veterans with prostate cancer who were on active surveillance, negative multiparametric MRI had a 75% negative predictive value for ruling out disease of grade group 2 or higher at ...
Peer reviewed publication details pivotal data, demonstrating 30% improvement in disease-free survival (DFS) in patients with ...
Biparametric MRI, which omits dynamic contrast-enhanced sequences, similarly detected clinically significant prostate cancer to multiparametric MRI. Biparametric MRI was also noninferior to ...
The Government has accepted a recommendation to introduce England’s first targeted prostate cancer screening programme.
Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data ...
MedPage Today on MSN
Treatment intensification slows metastatic hormone-sensitive prostate cancer
Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results